度伐利尤单抗联合化疗作为局部晚期非小细胞肺癌患者新辅助治疗方案的疗效与安全性
徐萌敏,杨剑烨,杨飞燕,胡汶斌,杨国彪
度伐利尤单抗联合化疗作为局部晚期非小细胞肺癌患者新辅助治疗方案的疗效与安全性
Efficacy and safety of durvalumab plus chemotherapy as neoadjuvant regimen in the treatment of locally advanced non-small cell lung cancer patients
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |